The state of New Jersey currently has 1 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
RAPA-501 Therapy for ALS
Recruiting
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/02/2024
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Amyotrophic Lateral Sclerosis